Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ · Healthcare
Arcturus Therapeutics Holdings Inc. Operating Income 2018–2025
Arcturus Therapeutics Holdings Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Arcturus Therapeutics Holdings Inc. operating income for the quarter ending March 31, 2026 was -28.9 M, a 71.94% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. operating income for the twelve months ending March 31, 2026 was -73.9 M, a 9.44% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. annual operating income for 2025 was -76.3 M, a 20.29% decrease from 2024.
- Arcturus Therapeutics Holdings Inc. annual operating income for 2024 was -95.7 M, a 22.33% increase from 2023.
- Arcturus Therapeutics Holdings Inc. annual operating income for 2023 was -78.2 M, a 742.24% decrease from 2022.
- Arcturus Therapeutics Holdings Inc. annual operating income for 2022 was 12.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcturus Therapeutics Holdings Inc. Operating Income — FAQ
Arcturus Therapeutics Holdings Inc. (ARCT) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcturus Therapeutics Holdings Inc.'s operating income?
Arcturus Therapeutics Holdings Inc. (ARCT) reported operating income of -$76M for fiscal 2025.
Where can I see ARCT's operating income history?
The chart and table above show Arcturus Therapeutics Holdings Inc.'s operating income by year and by quarter, including the growth rate.